nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—CYP3A4—prostate cancer	0.248	1	CbGaD
Ergoloid mesylate—SLCO2B1—Estrone—prostate cancer	0.196	0.278	CbGbCtD
Ergoloid mesylate—SLCO2B1—Conjugated Estrogens—prostate cancer	0.128	0.182	CbGbCtD
Ergoloid mesylate—SLCO2B1—Estradiol—prostate cancer	0.113	0.16	CbGbCtD
Ergoloid mesylate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0553	0.0785	CbGbCtD
Ergoloid mesylate—CYP3A4—Bicalutamide—prostate cancer	0.029	0.0412	CbGbCtD
Ergoloid mesylate—CYP3A4—Estramustine—prostate cancer	0.027	0.0383	CbGbCtD
Ergoloid mesylate—CYP3A4—Abiraterone—prostate cancer	0.0241	0.0342	CbGbCtD
Ergoloid mesylate—CYP3A4—Flutamide—prostate cancer	0.0241	0.0342	CbGbCtD
Ergoloid mesylate—CYP3A4—Cabazitaxel—prostate cancer	0.0178	0.0253	CbGbCtD
Ergoloid mesylate—CYP3A4—Estrone—prostate cancer	0.0174	0.0247	CbGbCtD
Ergoloid mesylate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0155	0.022	CbGbCtD
Ergoloid mesylate—CYP3A4—Conjugated Estrogens—prostate cancer	0.0114	0.0162	CbGbCtD
Ergoloid mesylate—CYP3A4—Mitoxantrone—prostate cancer	0.0103	0.0147	CbGbCtD
Ergoloid mesylate—CYP3A4—Estradiol—prostate cancer	0.00999	0.0142	CbGbCtD
Ergoloid mesylate—CYP3A4—Prednisone—prostate cancer	0.00859	0.0122	CbGbCtD
Ergoloid mesylate—CYP3A4—Etoposide—prostate cancer	0.00652	0.00927	CbGbCtD
Ergoloid mesylate—CYP3A4—Docetaxel—prostate cancer	0.00597	0.00848	CbGbCtD
Ergoloid mesylate—CYP3A4—Doxorubicin—prostate cancer	0.00445	0.00632	CbGbCtD
Ergoloid mesylate—Dihydroergotamine—CYP3A4—prostate cancer	0.000377	0.497	CrCbGaD
Ergoloid mesylate—Ergotamine—CYP3A4—prostate cancer	0.000194	0.256	CrCbGaD
Ergoloid mesylate—Bromocriptine—CYP3A4—prostate cancer	0.000187	0.247	CrCbGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CG—prostate cancer	1.33e-05	0.000281	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASP9—prostate cancer	1.32e-05	0.000278	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3CD—prostate cancer	1.29e-05	0.000272	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.29e-05	0.000272	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PRKCQ—prostate cancer	1.28e-05	0.000269	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NGFR—prostate cancer	1.28e-05	0.000269	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAP3K7—prostate cancer	1.26e-05	0.000266	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTHLH—prostate cancer	1.23e-05	0.000259	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFBR1—prostate cancer	1.23e-05	0.000259	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGF10—prostate cancer	1.21e-05	0.000256	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKR1C3—prostate cancer	1.21e-05	0.000255	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKACB—prostate cancer	1.2e-05	0.000254	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRB2—prostate cancer	1.2e-05	0.000253	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—JAK2—prostate cancer	1.19e-05	0.00025	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—MAP2K1—prostate cancer	1.18e-05	0.000249	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PPP3CA—prostate cancer	1.17e-05	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—THBS1—prostate cancer	1.17e-05	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CD—prostate cancer	1.17e-05	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VAV3—prostate cancer	1.17e-05	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ANXA1—prostate cancer	1.16e-05	0.000244	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFBR2—prostate cancer	1.16e-05	0.000243	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HPGD—prostate cancer	1.15e-05	0.000242	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.15e-05	0.000242	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ITPR1—prostate cancer	1.14e-05	0.00024	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKCZ—prostate cancer	1.14e-05	0.000239	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3CB—prostate cancer	1.13e-05	0.000237	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CG—prostate cancer	1.11e-05	0.000234	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGFR4—prostate cancer	1.1e-05	0.000231	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PARP1—prostate cancer	1.1e-05	0.000231	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1R—prostate cancer	1.09e-05	0.000229	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CALCA—prostate cancer	1.08e-05	0.000228	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—CXCL8—prostate cancer	1.08e-05	0.000228	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.08e-05	0.000228	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—JAK2—prostate cancer	1.08e-05	0.000227	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCL12—prostate cancer	1.06e-05	0.000223	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTAP—prostate cancer	1.05e-05	0.000221	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.05e-05	0.000221	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LPL—prostate cancer	1.04e-05	0.00022	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—IL2—prostate cancer	1.03e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PDGFRB—prostate cancer	1.03e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.02e-05	0.000216	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.02e-05	0.000216	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CB—prostate cancer	1.02e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CG—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ITGB3—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASP9—prostate cancer	9.96e-06	0.00021	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CXCL8—prostate cancer	9.83e-06	0.000207	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD17B3—prostate cancer	9.77e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ACSL4—prostate cancer	9.77e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ERBB3—prostate cancer	9.77e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CD—prostate cancer	9.76e-06	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGFR2—prostate cancer	9.75e-06	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NGFR—prostate cancer	9.65e-06	0.000203	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKCQ—prostate cancer	9.65e-06	0.000203	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAP3K7—prostate cancer	9.54e-06	0.000201	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL2—prostate cancer	9.39e-06	0.000198	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PHGDH—prostate cancer	9.37e-06	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—UMPS—prostate cancer	9.37e-06	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ARG2—prostate cancer	9.37e-06	0.000197	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TERT—prostate cancer	9.36e-06	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LDHB—prostate cancer	9.19e-06	0.000193	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF10—prostate cancer	9.17e-06	0.000193	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRB2—prostate cancer	9.08e-06	0.000191	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.02e-06	0.00019	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—JAK2—prostate cancer	8.95e-06	0.000189	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HIF1A—prostate cancer	8.95e-06	0.000189	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MAP2K1—prostate cancer	8.92e-06	0.000188	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CD—prostate cancer	8.86e-06	0.000187	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VAV3—prostate cancer	8.85e-06	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LEP—prostate cancer	8.74e-06	0.000184	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFBR2—prostate cancer	8.73e-06	0.000184	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TCN2—prostate cancer	8.71e-06	0.000183	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—UCP3—prostate cancer	8.71e-06	0.000183	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PDHA1—prostate cancer	8.71e-06	0.000183	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA3—prostate cancer	8.71e-06	0.000183	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CAV1—prostate cancer	8.66e-06	0.000182	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ITPR1—prostate cancer	8.59e-06	0.000181	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KDR—prostate cancer	8.56e-06	0.00018	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CB—prostate cancer	8.5e-06	0.000179	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ESR1—prostate cancer	8.34e-06	0.000176	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.31e-06	0.000175	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.31e-06	0.000175	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1R—prostate cancer	8.21e-06	0.000173	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CXCL8—prostate cancer	8.17e-06	0.000172	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—BAD—prostate cancer	8.14e-06	0.000171	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—JAK2—prostate cancer	8.13e-06	0.000171	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.96e-06	0.000168	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA4—prostate cancer	7.96e-06	0.000168	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CG—prostate cancer	7.89e-06	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APC—prostate cancer	7.89e-06	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LPL—prostate cancer	7.87e-06	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—IL2—prostate cancer	7.81e-06	0.000164	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PDGFRB—prostate cancer	7.8e-06	0.000164	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EGF—prostate cancer	7.79e-06	0.000164	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IRS1—prostate cancer	7.79e-06	0.000164	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA2—prostate cancer	7.76e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CB—prostate cancer	7.72e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SULT1A1—prostate cancer	7.67e-06	0.000161	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCG5—prostate cancer	7.67e-06	0.000161	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ITGB3—prostate cancer	7.6e-06	0.00016	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GSK3B—prostate cancer	7.57e-06	0.000159	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA1—prostate cancer	7.49e-06	0.000158	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INS—prostate cancer	7.46e-06	0.000157	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CXCL8—prostate cancer	7.42e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTO1—prostate cancer	7.4e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.4e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NAT2—prostate cancer	7.4e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ERBB3—prostate cancer	7.37e-06	0.000155	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGFR2—prostate cancer	7.36e-06	0.000155	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CREBBP—prostate cancer	7.31e-06	0.000154	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1—prostate cancer	7.22e-06	0.000152	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EGFR—prostate cancer	7.18e-06	0.000151	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLCB2—prostate cancer	7.1e-06	0.00015	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.1e-06	0.00015	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LRP2—prostate cancer	7.1e-06	0.00015	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL2—prostate cancer	7.09e-06	0.000149	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TERT—prostate cancer	7.07e-06	0.000149	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAP2K1—prostate cancer	6.98e-06	0.000147	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—P4HB—prostate cancer	6.96e-06	0.000147	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CD—prostate cancer	6.93e-06	0.000146	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3CA—prostate cancer	6.87e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SERPINE1—prostate cancer	6.86e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—KRAS—prostate cancer	6.79e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.77e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HIF1A—prostate cancer	6.76e-06	0.000142	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGF2—prostate cancer	6.64e-06	0.00014	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.6e-06	0.000139	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LEP—prostate cancer	6.6e-06	0.000139	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOS3—prostate cancer	6.55e-06	0.000138	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CAV1—prostate cancer	6.54e-06	0.000138	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MED12—prostate cancer	6.49e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KDR—prostate cancer	6.46e-06	0.000136	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GNG5—prostate cancer	6.44e-06	0.000136	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—JAK2—prostate cancer	6.36e-06	0.000134	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ESR1—prostate cancer	6.3e-06	0.000133	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CA—prostate cancer	6.24e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MDM2—prostate cancer	6.21e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA3—prostate cancer	6.21e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—BAD—prostate cancer	6.15e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ERBB2—prostate cancer	6.12e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CB—prostate cancer	6.04e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APC—prostate cancer	5.95e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CG—prostate cancer	5.95e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HPGDS—prostate cancer	5.92e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IRS1—prostate cancer	5.89e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EGF—prostate cancer	5.89e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.88e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CXCL8—prostate cancer	5.81e-06	0.000122	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTT1—prostate cancer	5.74e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ACHE—prostate cancer	5.74e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GSK3B—prostate cancer	5.71e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.68e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CDKN1B—prostate cancer	5.67e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INS—prostate cancer	5.64e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT1—prostate cancer	5.61e-06	0.000118	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASP3—prostate cancer	5.56e-06	0.000117	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL2—prostate cancer	5.55e-06	0.000117	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—prostate cancer	5.52e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.52e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CREBBP—prostate cancer	5.52e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PRKACB—prostate cancer	5.49e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1—prostate cancer	5.45e-06	0.000115	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.43e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EGFR—prostate cancer	5.42e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCND1—prostate cancer	5.41e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CTNNB1—prostate cancer	5.36e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAP2K1—prostate cancer	5.27e-06	0.000111	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP9—prostate cancer	5.25e-06	0.000111	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CD—prostate cancer	5.23e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CDKN1A—prostate cancer	5.23e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PTEN—prostate cancer	5.22e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	5.18e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA2—prostate cancer	5.18e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SERPINE1—prostate cancer	5.18e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—KRAS—prostate cancer	5.12e-06	0.000108	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT1—prostate cancer	5.09e-06	0.000107	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF2—prostate cancer	5.01e-06	0.000106	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EP300—prostate cancer	4.98e-06	0.000105	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOS3—prostate cancer	4.94e-06	0.000104	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.94e-06	0.000104	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SRC—prostate cancer	4.84e-06	0.000102	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.83e-06	0.000102	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—JAK2—prostate cancer	4.8e-06	0.000101	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NQO1—prostate cancer	4.77e-06	0.0001	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VEGFA—prostate cancer	4.72e-06	9.93e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	4.71e-06	9.92e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TH—prostate cancer	4.7e-06	9.9e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MDM2—prostate cancer	4.69e-06	9.88e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—STAT3—prostate cancer	4.67e-06	9.84e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ERBB2—prostate cancer	4.62e-06	9.74e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.57e-06	9.63e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CB—prostate cancer	4.56e-06	9.61e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GGT1—prostate cancer	4.43e-06	9.33e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCL8—prostate cancer	4.38e-06	9.23e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA1—prostate cancer	4.36e-06	9.19e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MYC—prostate cancer	4.34e-06	9.14e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFB1—prostate cancer	4.33e-06	9.12e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.3e-06	9.06e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CDKN1B—prostate cancer	4.28e-06	9.02e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EGFR—prostate cancer	4.24e-06	8.94e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT1—prostate cancer	4.24e-06	8.92e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASP3—prostate cancer	4.2e-06	8.84e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL2—prostate cancer	4.19e-06	8.82e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—prostate cancer	4.17e-06	8.78e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—RXRA—prostate cancer	4.15e-06	8.74e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCND1—prostate cancer	4.08e-06	8.6e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CTNNB1—prostate cancer	4.04e-06	8.52e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KRAS—prostate cancer	4.01e-06	8.44e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—COMT—prostate cancer	4e-06	8.42e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTP1—prostate cancer	3.98e-06	8.38e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP9—prostate cancer	3.97e-06	8.35e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CDKN1A—prostate cancer	3.95e-06	8.32e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTEN—prostate cancer	3.94e-06	8.3e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ITPR1—prostate cancer	3.92e-06	8.25e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT1—prostate cancer	3.85e-06	8.1e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EP300—prostate cancer	3.76e-06	7.92e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TYMS—prostate cancer	3.7e-06	7.79e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CA—prostate cancer	3.68e-06	7.76e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTM1—prostate cancer	3.66e-06	7.7e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SRC—prostate cancer	3.66e-06	7.7e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPL—prostate cancer	3.59e-06	7.56e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TP53—prostate cancer	3.56e-06	7.51e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VEGFA—prostate cancer	3.56e-06	7.5e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STAT3—prostate cancer	3.53e-06	7.43e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.47e-06	7.3e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ERCC2—prostate cancer	3.44e-06	7.24e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MYC—prostate cancer	3.28e-06	6.9e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFB1—prostate cancer	3.27e-06	6.88e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—prostate cancer	3.26e-06	6.87e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—prostate cancer	3.23e-06	6.81e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EGFR—prostate cancer	3.2e-06	6.75e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARA—prostate cancer	3.17e-06	6.68e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KRAS—prostate cancer	3.03e-06	6.38e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT1—prostate cancer	3.01e-06	6.34e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CAV1—prostate cancer	2.98e-06	6.28e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CA—prostate cancer	2.78e-06	5.86e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.72e-06	5.72e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TP53—prostate cancer	2.69e-06	5.67e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—INS—prostate cancer	2.57e-06	5.41e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CREBBP—prostate cancer	2.52e-06	5.3e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—prostate cancer	2.46e-06	5.19e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.39e-06	5.03e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT1—prostate cancer	2.27e-06	4.79e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NOS3—prostate cancer	2.25e-06	4.75e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.08e-06	4.38e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGS2—prostate cancer	2.06e-06	4.34e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTEN—prostate cancer	1.8e-06	3.79e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—EP300—prostate cancer	1.71e-06	3.61e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.27e-06	2.67e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKT1—prostate cancer	1.04e-06	2.18e-05	CbGpPWpGaD
